Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups

These days success and challenges of vaccines on infants, children, pregnant women and elderly patient is major concern for influenza research. Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Vaccine innovation and human health researchers try to determine how well flu vaccines work to regularly assess and confirm the value of flu vaccination as a public health intervention in each season. Study results about how well a flu vaccine works can vary based on study design, outcome(s) measured, population studied and the season in which the flu vaccine was studied. These differences can make it difficult to compare one study’s results with another’s. rough the support of the U.S. Department of Health and Human Services and NIAID, researchers are developing various influenza vaccine delivery technologies that will help the United States and the world be better prepared to mount a speedy response to the next pandemic

  • Vaccine innovation and human health
  • Effectiveness of multivalent vaccines
  • Developing a universal flu vaccine
  • Success and challenges of vaccines on infants, children, pregnant women and elderly patient
  • Various influenza vaccine delivery technologies

Related Conference of Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups

November 21-22, 2024

7th Pathology and Infectious Disease Conference

Dubai, UAE
November 21-22, 2024

8th International Conference on Rare Diseases

Dubai, UAE

New Approaches to Vaccines for Human and Veterinary Tropical Diseases

May 22 26 2016

18th International Conference on Vaccines and Immunization

February 22 - 23 2016

World Vaccine Congress

March 29 - 31 2016

The World Veterinary Vaccine Congress

November 09 - 11 2015

Modern Vaccines Adjuvants Formulation

May 18-20 2016

Incidence Severity and Impact of Influenza 2016

January 21 - 22 2016

Options IX for the Control of Influenza

August 24 - 26 2016

5th Anti-Virus Research Development

July 06 - 07 2016

Genetic Analyses of Influenza Viruses

November 21 - 22 2015

5th International Influenza Meeting

September 25-27 2016

Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in